{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Week in Review Desk", "lead_paragraph": "YOU might think if questions were raised about whether antidepressant drugs can make patients suicidal during the first few weeks of treatment, that scientists would turn to animal testing for further investigation. After all, suicides are rare enough that there are no firm human data on whether the drugs can cause them. But you can do experiments with animals -- examining their brains, giving them high doses of drugs -- that you could never do with people.", "headline": {"main": "Ideas & Trends: Of Mice and Men; Why Test Animals to Cure Human Depression?"}, "abstract": "Food and Drug Administration recently announced that it was so concerned about possible suicide risk that it wants antidepressant drugs to carry warnings on their labels; animal experiments are not option when testing antidepressant drugs because researchers do not have animal model of depression; photo (M)", "print_page": "3", "word_count": 866, "_id": "4fd23c0f8eb7c8105d7d129b", "snippet": "YOU might think if questions were raised about whether antidepressant drugs can make patients suicidal during the first few weeks of treatment, that scientists would turn to animal testing for further investigation.     After all, suicides are rare...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/03/28/weekinreview/ideas-trends-of-mice-and-men-why-test-animals-to-cure-human-depression.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "ANIMALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2004-03-28T00:00:00Z", "section_name": "Health; Week in Review"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "In advance of Tuesday's reports by the Social Security and Medicare trustees, some credulous journalists wrote stories based on tips from advocates of Social Security privatization, who claimed that the report would offer a radically downgraded vision of the system's future. False alarm: projections for Social Security are about the same as last year. Projections for Medicare, however, have worsened: last year the trustees predicted that the hospital insurance trust fund would last until 2026, and now they've moved it back to 2019. How should we react to this news?", "headline": {"main": "The Medicare Muddle"}, "abstract": "Paul Krugman Op-Ed column calls for calm in wake of news that Medicare funding is in dire straits; says it is like any government program and can be sustained by politicians; scores Bush administration because new Medicare drug bill 'squanders money' on HMO's; recounts that when, in 1997, Congress required Medicare to pay fees to private plans that accepted Medicare recipients, it turned into subsidy for HMO's because they only accepted healthy retirees; says private plans are much less efficient than government at providing insurance because they have much higher overhead and, even with subsidy, cannot compete with Medicare; says drug bill is going in same direction, should be scrapped and new one instituted (M)", "print_page": "19", "word_count": 725, "_id": "4fd24c138eb7c8105d7eb682", "snippet": "In advance of Tuesday's reports by the Social Security and Medicare trustees, some credulous journalists wrote stories based on tips from advocates of Social Security privatization, who claimed that the report would offer a radically downgraded...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/03/26/opinion/the-medicare-muddle.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "PRIVATIZATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Paul", "rank": 1, "lastname": "KRUGMAN"}], "original": "By PAUL KRUGMAN"}, "document_type": "article", "pub_date": "2004-03-26T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Patients taking antidepressants can become suicidal in the first weeks of therapy, and physicians should watch patients closely when first giving the drugs or changing dosages, federal regulators said yesterday. The warnings are part of a public health advisory issued by the Food and Drug Administration and are a reminder that antidepressants, taken by millions around the world, are not without risks. The agency is asking drug manufacturers to place detailed caveats about the drugs' side effects prominently on their labels.", "headline": {"main": "REGULATORS WANT ANTIDEPRESSANTS TO LIST WARNING"}, "abstract": "Food and Drug Administration issues public health advisory on antidepressants, warning that patients taking them can become suicidal in first weeks of therapy; says doctors should watch patients closely when first giving drugs or changing dosages; agency is asking drug manufacturers to place detailed caveats about drugs' side effects prominantly on their labels; agency issues advisory despite fact that no studies have shown convincing link between drug therapy and suicide; regulators say suicide is such a rare side effect that studies on subject have been difficult to interpret; series of secret studies conducted by drug companies that became public last year seemed to show that depressed children and teenagers given antidepressants were more likely to become suicidal than those given placebos; studies also showed that most antidepressants were not effective in treating depression in children and teenagers; FDA is still reviewing those studies; scientific advisory panel urged FDA to issue stronger warnings about possible link between antidepressants and suicide in teenagers and children; Dr Jeffrey Lieberman, psychiatry and pharmacology professor, says agency's action suggests that physicians have become too casual about dispensing antidepressants (M)", "print_page": "1", "word_count": 1222, "_id": "4fd2390b8eb7c8105d7cc693", "snippet": "Patients taking antidepressants can become suicidal in the first weeks of therapy, and physicians should watch patients closely when first giving the drugs or changing dosages, federal regulators said yesterday.    The warnings are part of a public...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/03/23/us/regulators-want-antidepressants-to-list-warning.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LIEBERMAN, JEFFREY A"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2004-03-23T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 3, "offset": 0, "time": 295}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}